What is Praxis Precision Medicines, Inc.'s EV / sales?

Praxis Precision Medicines, Inc. (PRAX) reported EV / sales of 129.5× in Q3 2025.

How has Praxis Precision Medicines, Inc.'s EV / sales changed year-over-year?

Praxis Precision Medicines, Inc.'s EV / sales decreased by 75.7% year-over-year, from 532.3× to 129.5×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Praxis Precision Medicines, Inc. PRAX EV / sales

EV / sales at other companies

Jazz PharmaceuticalsJAZZ

3.7×+1.0×

Axsome TherapeuticsAXSM

12.1×-0.9×

BiogenBIIB

3×+0.8×

AlkermesALKS

4.6×+1.2×

Neurocrine BiosciencesNBIX

4.3×-0.4×

TG TherapeuticsTGTX

8×-8.3×

Other financials

Income statement

See full

Revenue--100%

Operating income-$105.9M-41.7%

Net income-$92.6M-33.6%

EPS (diluted)-$3.20+2.7%

Balance sheet

See full

Cash & equivalents$536.7M+223%

Total debt$1.4M+31.3%

Total equity$1.4B+221%

Total assets$1.5B+205%

Cash flow

See full

Operating cash flow-$86.2M-62.5%

CapEx$62.0K—

Free cash flow-$86.2M-62.6%

Valuation

See full

Market cap$7.87B+1,075%

Enterprise value$7.34B+1,309%

Profitability

See full

Operating margin-3,927.5%-1,497pp

Net margin-3,658.5%-1,388pp

FCF margin-3,067.4%-1,030pp

Returns & leverage

See full

Return on equity-35.3%-10.9pp

Debt / equity0×0.0×

Current ratio15.9×+7.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

enterprise value/total revenue=129.5×

Based on the most recent quarter.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s EV / sales?: Praxis Precision Medicines, Inc. (PRAX) reported EV / sales of 129.5× in Q3 2025.
How has Praxis Precision Medicines, Inc.'s EV / sales changed year-over-year?: Praxis Precision Medicines, Inc.'s EV / sales decreased by 75.7% year-over-year, from 532.3× to 129.5×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.